While many Americans are familiar with the current decriminalization of marijuana, few are familiar with the decriminalization news of “magic mushrooms”. This year both Denver and Oakland decriminalized the magical plant due to it’s very low toxicity rating and positive health benefits (particularly for it’s natural anti-depressant and anti-anxiety purposes). In fact, in recent news man countries have begun to globally accept this fungal plant as a benign spiritual healer.
Scientifically known as Psilocybe Cubensis , this type of mushroom has been known to be used in early African and South American civilizations. For example, the Aztecas were known to use psilocybin for religious and celebratory purposes. With hundreds of years of research and knowledge of how our predecessors used magic mushrooms it’s long overdue that countries begin putting more money into research and teaching of this fungal species.
In recent news, botanical research firm of psychedelics Field Trip disclosed that they were building a 3,000 sq. ft. center at the University of West Indies (Mona, Jamaica) dedicated to magical mushroom research. According to reports, this would make Jamaica home of the first center solely dedicated to the benefits of this enigmatic plant.
“One of the goals is to build a library of psychoactive fungi and developing scalable commercialization options,” said Jafferi. “We know of a few alkaloids based in these mushrooms but there’s a lot we don’t know yet.”
Aside from developing its research lab, Field Trip also plans to open a series of clinics in Toronto, New York, London and Los Angeles where doctors will be able to prescribe ketamine and monitor patients seeking mental health treatment, Jafferi said.
He added that unlike cannabis, which can be used as medicine in an “as-needed” basis, there is already documented research from the 1970s that suggest psychedelics are an effective treatment for mental health when they are prescribed in a controlled and safe setting.
“It’s not that far out for us to see doctors prescribing some psychedelics for a particular mental health disorder,” Jafferi said. “